Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples